| Primary |
| Product Used For Unknown Indication |
47.0% |
| Blood Cholesterol Increased |
12.1% |
| Hypercholesterolaemia |
9.3% |
| Hypertension |
5.4% |
| Hyperlipidaemia |
5.2% |
| Myocardial Ischaemia |
2.6% |
| Blood Cholesterol |
2.0% |
| Dyslipidaemia |
1.9% |
| Atrial Fibrillation |
1.8% |
| Diabetes Mellitus |
1.7% |
| Prophylaxis |
1.7% |
| Myocardial Infarction |
1.4% |
| Type 2 Diabetes Mellitus |
1.4% |
| Coronary Artery Disease |
1.2% |
| Chronic Obstructive Pulmonary Disease |
1.0% |
| Neuralgia |
0.9% |
| Constipation |
0.9% |
| Depression |
0.8% |
| Osteomyelitis Chronic |
0.8% |
| Cerebrovascular Accident |
0.8% |
|
| Rhabdomyolysis |
19.9% |
| Myalgia |
14.6% |
| Product Substitution Issue |
11.1% |
| Abortion Spontaneous |
7.6% |
| Vomiting |
4.5% |
| Pain In Extremity |
3.7% |
| Pain |
3.5% |
| Rash |
3.5% |
| Weight Decreased |
3.5% |
| Palpitations |
3.3% |
| Paraesthesia |
3.1% |
| Product Quality Issue |
2.9% |
| Nausea |
2.7% |
| Headache |
2.5% |
| Pruritus |
2.5% |
| Hallucination |
2.3% |
| Myositis |
2.1% |
| Panic Attack |
2.1% |
| Urinary Incontinence |
2.1% |
| Arthritis |
2.0% |
|
| Secondary |
| Product Used For Unknown Indication |
39.4% |
| Drug Use For Unknown Indication |
10.2% |
| Hypertension |
8.4% |
| Hypercholesterolaemia |
6.7% |
| Blood Cholesterol Increased |
6.0% |
| Hyperlipidaemia |
5.3% |
| Type 2 Diabetes Mellitus |
4.4% |
| Atrial Fibrillation |
3.2% |
| Diabetes Mellitus |
2.7% |
| Dyslipidaemia |
1.7% |
| Depression |
1.5% |
| Acute Coronary Syndrome |
1.3% |
| Pain |
1.3% |
| Hiv Infection |
1.3% |
| Angina Pectoris |
1.2% |
| Rheumatoid Arthritis |
1.2% |
| Prophylaxis |
1.1% |
| Myocardial Ischaemia |
1.1% |
| Polyuria |
1.0% |
| Analgesic Therapy |
0.9% |
|
| Rhabdomyolysis |
13.3% |
| Myalgia |
9.2% |
| Hallucination |
8.1% |
| Completed Suicide |
7.3% |
| Vomiting |
6.9% |
| Renal Failure Acute |
6.6% |
| Colitis Microscopic |
4.3% |
| Drug Interaction |
4.1% |
| Renal Failure |
4.1% |
| Weight Decreased |
4.1% |
| Somnolence |
3.7% |
| Myasthenia Gravis |
3.6% |
| Androgenetic Alopecia |
3.4% |
| Overdose |
3.4% |
| High Density Lipoprotein Decreased |
3.2% |
| Toxicity To Various Agents |
3.2% |
| Amyotrophic Lateral Sclerosis |
3.0% |
| Pain In Extremity |
3.0% |
| Nausea |
2.8% |
| Rash |
2.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
41.4% |
| Drug Use For Unknown Indication |
11.8% |
| Hypertension |
11.4% |
| Diabetes Mellitus |
3.9% |
| Rheumatoid Arthritis |
3.7% |
| Type 2 Diabetes Mellitus |
3.4% |
| Atrial Fibrillation |
3.0% |
| Prophylaxis |
2.6% |
| Pain |
2.4% |
| Blood Cholesterol Increased |
2.4% |
| Depression |
2.1% |
| Hypercholesterolaemia |
2.0% |
| Hyperlipidaemia |
1.5% |
| Cardiac Disorder |
1.3% |
| Chronic Obstructive Pulmonary Disease |
1.3% |
| Acute Coronary Syndrome |
1.2% |
| Coronary Artery Disease |
1.2% |
| Osteoporosis |
1.2% |
| Myocardial Infarction |
1.2% |
| Myocardial Ischaemia |
1.2% |
|
| Vomiting |
12.6% |
| Myocardial Infarction |
9.0% |
| Renal Failure Acute |
8.3% |
| Weight Decreased |
6.5% |
| Weight Increased |
5.8% |
| Syncope |
4.9% |
| Urinary Tract Infection |
4.4% |
| Drug Ineffective |
4.3% |
| Nausea |
4.3% |
| Thrombocytopenia |
4.2% |
| Tremor |
4.2% |
| Pneumonia |
4.1% |
| Death |
3.9% |
| Dyspnoea |
3.8% |
| Renal Failure |
3.6% |
| International Normalised Ratio Increased |
3.4% |
| Pain |
3.2% |
| Pyrexia |
3.2% |
| White Blood Cell Count Increased |
3.2% |
| Transient Ischaemic Attack |
3.1% |
|
| Interacting |
| Product Used For Unknown Indication |
25.6% |
| Drug Use For Unknown Indication |
8.7% |
| Mental Disorder |
7.6% |
| Dyslipidaemia |
7.1% |
| Hypertension |
6.5% |
| Depression |
5.1% |
| Acute Myocardial Infarction |
4.7% |
| Deep Vein Thrombosis |
4.5% |
| Lipids Abnormal |
3.6% |
| Somatoform Disorder |
3.6% |
| Pain |
3.1% |
| Hiv Infection |
2.9% |
| Blood Cholesterol Increased |
2.7% |
| Hypercholesterolaemia |
2.4% |
| Prophylaxis |
2.4% |
| Hyperlipidaemia |
2.2% |
| Cerebrovascular Accident |
2.0% |
| Diabetes Mellitus |
1.8% |
| Herpes Zoster |
1.8% |
| Menopause |
1.8% |
|
| Rhabdomyolysis |
32.7% |
| Drug Interaction |
20.9% |
| High Density Lipoprotein Decreased |
9.1% |
| Polymyositis |
4.5% |
| Suicidal Ideation |
3.6% |
| Haemorrhage |
2.7% |
| Renal Failure Acute |
2.7% |
| Akathisia |
1.8% |
| Anuria |
1.8% |
| Apolipoprotein A-i Decreased |
1.8% |
| Gamma-glutamyltransferase Increased |
1.8% |
| General Physical Health Deterioration |
1.8% |
| Hepatitis Toxic |
1.8% |
| Muscular Weakness |
1.8% |
| Myocardial Infarction |
1.8% |
| Nephropathy |
1.8% |
| Oedema Peripheral |
1.8% |
| Pain In Extremity |
1.8% |
| Physical Assault |
1.8% |
| Pneumonia |
1.8% |
|
